The diagnostic use of ERG in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies beyond that provided by basal cell and α-methylacyl-CoA-racemase markers

Human Pathology

Volumn 44, Issue 5, 2013, Pages 786-794

  Shah, Rajal B ^a   Tadros, Yousef ^a   Brummell, Brenda ^a   Zhou, Ming ^b  

^a Division of Urologic Pathology   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

Methylacyl CoA racemase (AMACR); ERG; High molecular weight cytokeratin (HMWCK); p63; Prostate cancer

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; CYTOKERATIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN P63; TRANSCRIPTION FACTOR ERG;

ADULT; AGED; ARTICLE; BASAL CELL; CELL STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84876466414     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.06.024     Document Type: Article

References (29)

1. S.A. Tomlins, D.R. Rhodes, and S. Perner Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 310 2005 644 648 (Pubitemid 41528150)
2. R. Mehra, S.A. Tomlins, and R. Shen Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer Mod Pathol 20 2007 538 544 (Pubitemid 46631996)
3. J.M. Mosquera, R. Mehra, and M.M. Regan Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States Clin Cancer Res 15 2009 4706 4711
4. S. Perner, F. Demichelis, and R. Beroukhim TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer Cancer Res 66 2006 8337 8341 (Pubitemid 44449140)
5. R.B. Shah, and A.M. Chinnaiyan The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications Adv Anat Pathol 16 2009 145 153
6. B. Han, R. Mehra, and R.J. Lonigro Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression Mod Pathol 22 2009 1083 1093
7. J.M. Mosquera, S. Perner, and E.M. Genega Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications Clin Cancer Res 14 2008 3380 3385
8. B. Furusato, S.H. Tan, and D. Young ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification Prostate Cancer Prostatic Dis 13 2010 228 237
9. S. Perner, J.M. Mosquera, and F. Demichelis TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion Am J Surg Pathol 31 2007 882 888 (Pubitemid 47165141)
10. B. Han, R. Mehra, and K. Suleman Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma Mod Pathol 22 2009 1176 1185
11. K. Park, S.A. Tomlins, and K.M. Mudaliar Antibody-based detection of ERG rearrangement-positive prostate cancer Neoplasia 12 2010 590 598
12. G. Petrovics, A. Liu, and S. Shaheduzzaman Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome Oncogene 24 2005 3847 3852 (Pubitemid 40826884)
13. S.M. Falzarano, M. Zhou, and P. Carver ERG gene rearrangement status in prostate cancer detected by immunohistochemistry Virchows Arch 459 2011 441 447
14. A. Chaux, R. Albadine, and A. Toubaji Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas Am J Surg Pathol 35 2011 1014 1020
15. O. Yaskiv, X. Zhang, and K. Simmerman The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies Am J Surg Pathol 35 2011 1062 1068
16. O. Hameed, and P.A. Humphrey Immunohistochemistry in diagnostic surgical pathology of the prostate Semin Diagn Pathol 22 2005 88 104 (Pubitemid 43168177)
17. M. Varma, and B. Jasani Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature Histopathology 47 2005 1 16 (Pubitemid 40978808)
18. C.G. Przybycin, L.P. Kunju, A.J. Wu, and R.B. Shah Partial atrophy in prostate needle biopsies: a detailed analysis of its morphology, immunophenotype, and cellular kinetics Am J Surg Pathol 32 2008 58 64
19. R.B. Shah, L.P. Kunju, R. Shen, M. LeBlanc, M. Zhou, and M.A. Rubin Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations Am J Clin Pathol 122 2004 517 523 (Pubitemid 39281247)
20. R.B. Shah, M. Zhou, M. LeBlanc, M. Snyder, and M.A. Rubin Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer Am J Surg Pathol 26 2002 1161 1168 (Pubitemid 34969185)
21. B.R. Oliai, H. Kahane, and J.I. Epstein Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody Am J Surg Pathol 26 2002 1151 1160 (Pubitemid 34969184)
22. A.O. Osunkoya, D.E. Hansel, X. Sun, G.J. Netto, and J.I. Epstein Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases Am J Surg Pathol 32 2008 461 467 (Pubitemid 351398939)
23. L.P. Kunju, A.M. Chinnaiyan, and R.B. Shah Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer Histopathology 47 2005 587 596 (Pubitemid 41775181)
24. L.P. Kunju, M.A. Rubin, A.M. Chinnaiyan, and R.B. Shah Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations Am J Clin Pathol 120 2003 737 745 (Pubitemid 37339682)
25. M. Zhou, H. Aydin, H. Kanane, and J.I. Epstein How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? Am J Surg Pathol 28 2004 239 243 (Pubitemid 38124733)
26. M. Miettinen, Z.F. Wang, and A. Paetau ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma Am J Surg Pathol 35 2011 432 441
27. H. He, C. Magi-Galluzzi, and J. Li The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer Am J Surg Pathol 35 2011 608 614
28. R. Mehra, B. Han, and S.A. Tomlins Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases Cancer Res 67 2007 7991 7995 (Pubitemid 47395131)
29. M. Zhou, R. Shah, R. Shen, and M.A. Rubin Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells Am J Surg Pathol 27 2003 365 371 (Pubitemid 36245802)